Clinical Trials Logo

Filter by:
NCT ID: NCT05797025 Recruiting - Neck Pain Clinical Trials

Investigation of Pressure Pain Threshold and Pinch Grip Strength in Individuals With and Without Chronic Neck Pain

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

This study aims to determine whether there is a difference in pressure pain threshold and pinch grip strength in individuals with and without chronic neck pain.

NCT ID: NCT05797012 Recruiting - Migraine Disorders Clinical Trials

The Association Among Headache Severity, Head Posture, Cervical Muscle Endurance, and Neck Disorders in Individuals With Migraine

Start date: April 1, 2023
Phase: N/A
Study type: Interventional

To determine the relationship among headache severity, head posture, cervical muscle endurance and neck disorders in individuals with migraine.

NCT ID: NCT05796869 Recruiting - Food Habits Clinical Trials

The Effect of Laughter Therapy On The Food Craving

Start date: November 20, 2023
Phase: N/A
Study type: Interventional

Premenstrual syndrome (PMS) is characterized by physical, emotional, and behavioral symptoms in the luteal phase that significantly disrupt women's daily lives, including work and personal activities, and resolve spontaneously within a few days of the onset of menstruation. The premenstrual syndrome causes emotional eating, excessive consumption of certain foods, and increased appetite. These unhealthy eating patterns in eating behavior affect health negatively. Women with PMS have an increased appetite and food cravings. It has been stated that the increase in appetite and food cravings are reduced by laughter therapy. Thus, the laughter therapy method, which has no side effects in PMS and negative eating behaviors, can be used and recommended or applied by health professionals.

NCT ID: NCT05796180 Not yet recruiting - Clinical trials for Health Knowledge, Attitudes, Practice

Sexual Health Counseling Based on the BETTER Model

Start date: May 2024
Phase: N/A
Study type: Interventional

In this study, the investigators wanted to examine the effect of sexual health counseling to women in the postpartum period on the quality of life of the participants.

NCT ID: NCT05795998 Completed - Clinical trials for Unrecognized Condition

Turkish Adaptation of Romantic Relationship Sabotage Scale Validity and Reliability Study

T-RSS
Start date: January 15, 2022
Phase:
Study type: Observational [Patient Registry]

In this cross-sectional and relationship-seeking study, it was aimed to adapt the Romantic Relationship Sabotage Scale (T-RSS), developed by Racquel Peel, into Turkish, for the reasons why partners sabotage the relationship in romantic relationships.

NCT ID: NCT05795868 Completed - Pregnancy Related Clinical Trials

The Effect of Compression Stockings on the Complaints of Pregnant Women With Restless Leg Syndrome

Start date: April 25, 2022
Phase: N/A
Study type: Interventional

The aim of this project is to determine the effect of compression stockings on the complaints, well-being and sleep quality of pregnant women with restless legs syndrome (RLS). The research is a pretest-posttest randomized placebo-controlled experimental study. The study will be carried out with a total of 70 people, 35 in the compression stocking group and 35 in the placebo stocking group. Study data will be collected with RLS Diagnostic Criteria Questionnaire Form, Research Criteria Compliance Form, Personal Information Form, RLS Severity Rating Scale, Pittsburgh Sleep Quality Index (PUKI), WHO-5 and Implementation Satisfaction Form. Pregnant women in both groups will wear the stockings given for three weeks after the first interview. Data analysis obtained in the research will be performed in TURCOSA statistical software (Turcosa Analytics Ltd Co, Turkey, www.turcosa.com.tr).In comparisons, a value of p <0.05 will be considered statistically significant. In order to conduct the study, the necessary Academic Committee decision, Ethics Committee approval (December 08, 2021 and number 2021/781) and institutional permission were obtained. The individuals included in the study will be informed about the purpose of the research, their verbal consent will be obtained and the participant's informed consent form will be signed.

NCT ID: NCT05795777 Completed - Pressure Ulcer Clinical Trials

Examination of the Pressure Ulcers in Intensive Care Patients.

Start date: November 1, 2019
Phase:
Study type: Observational

A pressure sore was localized skin and/or subcutaneous tissue injury, usually caused by pressure alone or a combination of shear and pressure, at bony prominences. Pressure sores, which are an indicator of the quality of health care, increase mortality, morbidity and cost. Pressure ulcers are the most common problem in intensive care patients and should be prevented. In the literature, the incidence of pressure ulcers in intensive care patients is between 1-59.9%. A pressure sore is a localized injury to the skin and/or underlying soft tissue, usually over a bony prominence or associated with medical or other devices. This injury occurs when intense and/or prolonged pressure or pressure is accompanied by shear. Soft tissue tolerance to pressure and shear; temperature and humidity can affect nutrition, perfusion, concomitant conditions, and condition of soft tissue. This study was carried out to determine the prevalence of pressure ulcers and influencing factors in patients hospitalized in the 3rd level intensive care unit of a university hospital. Design: It is a descriptive, prospective, observational type study. Materials and Methods: The sample of the study consisted of 176 patients aged 18 years and above, 24 hours after hospitalization in the intensive care units of a University Hospital. Patient Information Form and Braden Scale for Predicting Pressure Ulcer Risk, Glasgow Coma Scale were used to collecting data. Statistical Package in statistical analysis for the social sciences 20.0 program was used.

NCT ID: NCT05795725 Recruiting - Colon Cancer Clinical Trials

Evaluation of the Diagnostic Potential of Artificial Intelligence-assisted Fecal Microbiome Testing for Colon Cancer

Start date: May 1, 2023
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to evaluate the diagnostic potential of Artificial Intelligence-assisted Fecal Microbiome Testing for the diagnosis of colon cancer. The main question it aims to answer is: • Is Artificial Intelligence-assisted Fecal Microbiome Testing a reliable screening test for colon cancer? Participants will be asked to provide fecal samples to be analyzed with next-generation sequencing techniques. If there is a comparison group: Researchers will compare the diagnostic performance of AI-assisted Fecal Microbiome Testing with colonoscopy to see the correlation between the results of both interventions.

NCT ID: NCT05795426 Recruiting - Volleyball Player Clinical Trials

Investigation of Kinesiophobia in Volleyball Players by Gender

Start date: March 6, 2024
Phase:
Study type: Observational

Kinesiophobia is a form of behavior that includes fear and anxiety in which the person tends to stay away from the movement. . In the future, this may lead to a decrease in muscle strength and condition, leading to loss or decrease in physical adequacy, avoidance of exercise and, accordingly, psychological problems. Kinesiophobia also negatively affects the success of the treatment process in athletes or normal patients.

NCT ID: NCT05795153 Completed - Clinical trials for Chronic Spontaneous Urticaria

A Multicenter, Open-label Phase 3 Study: Ambulatory Blood Pressure Monitoring in Adult Patients With Chronic Spontaneous Urticaria Inadequately Controlled by H1-antihistamines Treated With Remibrutinib up to 12 Weeks.

Start date: April 5, 2023
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to rule out an increase of >3mmHg in 24-hour average Systolic Blood Pressure at steady state (Week 4) compared to baseline. ABPM was chosen for the blood pressure assessment in this trial as recommended by the FDA for drugs intended for chronic use (Assessment of Pressor Effects of Drugs Guidance for Industry (FDA 2022)).